C172H212Cl4N40O16 — CID 158225635
3-(6-chloro-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-chloro-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one (PubChem CID 158225635) has the molecular formula C172H212Cl4N40O16 and a molecular weight of 3237.66 g/mol. Its IUPAC name is 3-(6-chloro-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-chloro-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one.
| Compound Name | 3-(6-chloro-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-chloro-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one |
|---|---|
| PubChem CID | 158225635 |
| Molecular Formula | C172H212Cl4N40O16 |
| Molecular Weight | 3237.66 g/mol |
| Exact Mass | 3233.58 |
| IUPAC Name | 3-(6-chloro-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-chloro-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-chloro-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-1H-benzimidazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(6-cyclopropyl-2H-benzotriazol-4-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indazol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one;3-(5-cyclopropyl-1H-indol-7-yl)-1-[4-(1-prop-2-enoylazetidin-3-yl)piperazin-1-yl]propan-1-one |
| SMILES | C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(C4CC4)cc4[nH]cnc34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(C4CC4)cc4cc[nH]c34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(C4CC4)cc4cn[nH]c34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(C4CC4)cc4n[nH]nc34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(Cl)cc4[nH]cnc34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(Cl)cc4cc[nH]c34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(Cl)cc4cn[nH]c34)CC2)C1.C=CC(=O)N1CC(N2CCN(C(=O)CCc3cc(Cl)cc4n[nH]nc34)CC2)C1 |
| InChI | InChI=1S/C24H30N4O2.2C23H29N5O2.C22H28N6O2.C21H25ClN4O2.2C20H24ClN5O2.C19H23ClN6O2/c1-2-22(29)28-15-21(16-28)26-9-11-27(12-10-26)23(30)6-5-18-13-20(17-3-4-17)14-19-7-8-25-24(18)19;1-2-21(29)28-13-19(14-28)26-7-9-27(10-8-26)22(30)6-5-17-11-18(16-3-4-16)12-20-23(17)25-15-24-20;1-2-21(29)28-14-20(15-28)26-7-9-27(10-8-26)22(30)6-5-17-11-18(16-3-4-16)12-19-13-24-25-23(17)19;1-2-20(29)28-13-18(14-28)26-7-9-27(10-8-26)21(30)6-5-16-11-17(15-3-4-15)12-19-22(16)24-25-23-19;1-2-19(27)26-13-18(14-26)24-7-9-25(10-8-24)20(28)4-3-15-11-17(22)12-16-5-6-23-21(15)16;1-2-18(27)26-12-17(13-26)24-5-7-25(8-6-24)19(28)4-3-14-9-16(21)10-15-11-22-23-20(14)15;1-2-18(27)26-11-16(12-26)24-5-7-25(8-6-24)19(28)4-3-14-9-15(21)10-17-20(14)23-13-22-17;1-2-17(27)26-11-15(12-26)24-5-7-25(8-6-24)18(28)4-3-13-9-14(20)10-16-19(13)22-23-21-16/h2,7-8,13-14,17,21,25H,1,3-6,9-12,15-16H2;2,11-12,15-16,19H,1,3-10,13-14H2,(H,24,25);2,11-13,16,20H,1,3-10,14-15H2,(H,24,25);2,11-12,15,18H,1,3-10,13-14H2,(H,23,24,25);2,5-6,11-12,18,23H,1,3-4,7-10,13-14H2;2,9-11,17H,1,3-8,12-13H2,(H,22,23);2,9-10,13,16H,1,3-8,11-12H2,(H,22,23);2,9-10,15H,1,3-8,11-12H2,(H,21,22,23) |
| InChIKey | GDTMXGRZCBGNMK-UHFFFAOYSA-N |
| XLogP | 14.42 |
| TPSA | 580.32 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 44 |
| Heavy Atoms | 232 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3237.66 |
| LogP ≤ 5 | 14.42 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 32 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|